AXQ Capital LP decreased its holdings in shares of Genpact Limited (NYSE:G – Free Report) by 41.4% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 20,674 shares of the business services provider’s stock after selling 14,593 shares during the quarter. AXQ Capital LP’s holdings in Genpact were worth $866,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Royal Bank of Canada lifted its holdings in shares of Genpact by 19.7% during the first quarter. Royal Bank of Canada now owns 121,705 shares of the business services provider’s stock worth $6,131,000 after buying an additional 20,043 shares during the last quarter. Amundi acquired a new stake in shares of Genpact in the first quarter worth $58,000. Goldman Sachs Group Inc. increased its position in Genpact by 20.8% during the first quarter. Goldman Sachs Group Inc. now owns 353,074 shares of the business services provider’s stock worth $17,788,000 after acquiring an additional 60,887 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its stake in Genpact by 12.4% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 511,627 shares of the business services provider’s stock valued at $25,776,000 after purchasing an additional 56,557 shares during the last quarter. Finally, Focus Partners Wealth raised its stake in Genpact by 10.3% during the 1st quarter. Focus Partners Wealth now owns 5,227 shares of the business services provider’s stock valued at $263,000 after purchasing an additional 488 shares during the last quarter. Institutional investors and hedge funds own 96.03% of the company’s stock.
Insiders Place Their Bets
In other Genpact news, SVP Sameer Dewan sold 15,088 shares of the firm’s stock in a transaction dated Tuesday, January 13th. The shares were sold at an average price of $46.65, for a total value of $703,855.20. Following the completion of the sale, the senior vice president owned 37,749 shares in the company, valued at approximately $1,760,990.85. This trade represents a 28.56% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, SVP Riju Vashisht sold 16,016 shares of the company’s stock in a transaction that occurred on Tuesday, January 13th. The stock was sold at an average price of $46.65, for a total transaction of $747,146.40. Following the transaction, the senior vice president owned 95,521 shares in the company, valued at $4,456,054.65. The trade was a 14.36% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Company insiders own 2.80% of the company’s stock.
Analyst Upgrades and Downgrades
Check Out Our Latest Report on Genpact
Genpact Price Performance
NYSE:G opened at $37.55 on Tuesday. The company has a quick ratio of 1.51, a current ratio of 1.66 and a debt-to-equity ratio of 0.46. The firm has a market cap of $6.47 billion, a PE ratio of 12.00, a price-to-earnings-growth ratio of 1.14 and a beta of 0.74. Genpact Limited has a 12 month low of $34.79 and a 12 month high of $54.00. The company’s 50-day moving average price is $44.16 and its two-hundred day moving average price is $43.29.
Genpact (NYSE:G – Get Free Report) last announced its earnings results on Thursday, February 5th. The business services provider reported $0.97 EPS for the quarter, topping the consensus estimate of $0.93 by $0.04. The business had revenue of $1.32 billion for the quarter, compared to the consensus estimate of $1.31 billion. Genpact had a return on equity of 22.02% and a net margin of 10.88%.Genpact’s revenue was up 5.6% compared to the same quarter last year. During the same period in the previous year, the business earned $0.91 EPS. Genpact has set its FY 2026 guidance at 4.010-4.010 EPS and its Q1 2026 guidance at 0.920-0.930 EPS. On average, equities analysts anticipate that Genpact Limited will post 3.21 EPS for the current fiscal year.
Genpact Increases Dividend
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, March 31st. Stockholders of record on Monday, March 16th will be issued a dividend of $0.1875 per share. The ex-dividend date is Monday, March 16th. This is a boost from Genpact’s previous quarterly dividend of $0.17. This represents a $0.75 annualized dividend and a dividend yield of 2.0%. Genpact’s dividend payout ratio (DPR) is currently 21.73%.
About Genpact
Genpact is a global professional services firm specializing in digitally powered business process management and services. The company partners with clients across industries to design, transform and run key operations, leveraging data analytics, artificial intelligence, automation and domain expertise. Its offerings span finance and accounting, supply chain management, procurement, customer experience, risk and compliance, and other critical business functions.
Founded in 1997 as the business process outsourcing arm of General Electric and originally known as GE Capital International Services, the company rebranded as Genpact in 2005 and completed its initial public offering on the New York Stock Exchange in 2007 under the ticker symbol “G.” Over time, Genpact has expanded beyond traditional outsourcing to focus on digital transformation and innovation, helping organizations accelerate growth and improve operational efficiency.
Headquartered in New York City, Genpact serves clients in more than 30 countries across North America, Latin America, Europe and Asia Pacific.
Further Reading
- Five stocks we like better than Genpact
- Elon Musk already made me a “wealthy man”
- Elon’s Secret AI Partner?
- Elon Musk: This Could Turn $100 into $100,000
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- REVEALED: Something Big Happening Behind White House Doors
Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.
